Gilead’s History
Transforming Treatment in HIV and Hep C
Over the last three decades we’ve created revolutionary therapies for people living with HIV and hepatitis C, and developed a reputation for innovation that’s second to none.
scroll

Hepatitis C
We introduced 4 medicines in less than 4 years that offer a cure for the majority of people living with chronic hepatitis C.

HIV
We pioneered the first-single tablet HIV regimen and developed the first medicine to prevent HIV infection.

Innovation
Ranked number 1 in the 2019 Pharmaceutical Innovation Index.
Galapagos’ Vision
Pioneering Research to Create Unique Targeted Therapies
Driven by a need to make great things happen, we’ve used state-of-the-art human biotechnology to discover and develop unique therapies.
scroll

Discovery
A bold and agile approach to drug discovery, powered by the philosophy: If it doesn’t happen, make it happen.

Biotech
Cutting-edge biotech that uses human cells from patients to discover novel targets for medicines to beat severe diseases.

Platform
A unique discovery platform that uses a vast adenoviral library to identify specific protein targets at the root cause of chronic disease, develop small molecule therapies aimed at those novel targets, and bring molecules rapidly to clinical trials.